ALMIRALL SA (LBTSF)
Clinical trial NCT06923202 updates: 1. start date: 2026-01-30 → 2026-02-10 2. completion date: 2026-11-26 → 2027-02-10 3. primary completion date: 2026-11-26 → 2027-02-10
Clinical trial NCT06923202 updates: 1. start date: 2026-01-30 → 2026-02-10 2. completion date: 2026-11-26 → 2027-02-10 3. primary completion date: 2026-11-26 → 2027-02-10
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical